Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...

View post: Nancy Guthrie Update: Sheriff’s Department Releases New Statement With more states and countries around the globe legalizing cannabis for personal use, scientists have been publishing ...

Scientific research in areas such as drug development and the food industry requires rigorous testing of new chemical compounds to determine their safety for the open market and human use. One vital ...

Forbes contributors publish independent expert analyses and insights. Emily Earlenbaugh covers cannabis science and culture. As cannabis legalization continues to increase globally, researchers are ...

In a recent study published in Addiction Biology, authors explored the mechanisms of cannabinoid-induced mitochondrial stress, micronuclear formation, and genotoxic damage and their implications for ...

Engineered nanomaterials are deliberately structured particles with dimensions typically below 100 nanometres, valued for their unique electrical, optical and catalytic properties. Their rapid uptake ...

Identifying and verifying low frequencies of genomic alterations resulting from off-target editing, gRNA synthesis errors, cross-contamination, or other unintended gRNA activity is critical to ...

The US Food and Drug Administration (FDA) announced it has released new, harmonized guidance for sponsors looking to conduct genotoxicity testing and data interpretation for human drug products. The ...

The company stated these genotoxicity studies represent a safety requirement for IND submission to the U.S. Food and Drug Administration. EB-003 is designed to engage both 5-HT2A and 5-HT1B receptors.

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, ...